Guardant Health to Participate in Upcoming Investor Conferences

About this update from Guardant Health, Inc.

PALO ALTO, Calif., February 03, 2026 --( BUSINESS WIRE )--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Interested parties may access live and archived webcasts of the sessions on the "Investors" section of the company website at: www.guardanthealth.com . About Guardant Health Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn , X (Twitter) and Facebook . Source: Guardant Health, Inc. View source version on businesswire.com: https://www.businesswire.com/news/home/20260203339557/en/ Contacts Investor Contact: Zarak Khurshid [email protected] Media Contact: Meaghan Smith [email protected]

View stock analysis, news, and events for Guardant Health, Inc.